Discovering eight novel pathogenic variants in the IDS gene in our cohort significantly enhances our understanding of MPS II’s genotypic spectrum, providing crucial insights into the disease’s underlying molecular mechanisms. This evidence concerns the gene IDS and mucopolysaccharidosis type 2.